Organigram Global Inc.
OGI
$1.41
-$0.03-2.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.31% | 168.85% | 70.52% | 63.78% | 13.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.31% | 168.85% | 70.52% | 63.78% | 13.92% |
| Cost of Revenue | 39.67% | 156.29% | 63.22% | 58.14% | -5.55% |
| Gross Profit | 69.47% | 204.03% | 84.60% | 80.23% | 100.38% |
| SG&A Expenses | 35.65% | 148.72% | 55.84% | -0.98% | 0.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.74% | 151.98% | 57.80% | 30.27% | -7.06% |
| Operating Income | 49.54% | -96.65% | 55.01% | 52.97% | 56.91% |
| Income Before Tax | 187.34% | -203.20% | -668.45% | 246.78% | -41.66% |
| Income Tax Expenses | -- | -12,512.27% | -- | -231.39% | -- |
| Earnings from Continuing Operations | 187.34% | -193.97% | -320.89% | 247.31% | -41.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 187.34% | -193.97% | -320.89% | 247.31% | -41.66% |
| EBIT | 49.54% | -96.65% | 55.01% | 52.97% | 56.91% |
| EBITDA | 136.97% | -86.72% | 243.25% | 76.39% | 73.46% |
| EPS Basic | 173.60% | -148.90% | -272.59% | 204.04% | -1.19% |
| Normalized Basic EPS | 190.62% | -97.49% | 27.08% | 65.06% | 15.80% |
| EPS Diluted | 172.56% | -148.92% | -278.95% | 200.59% | -1.19% |
| Normalized Diluted EPS | 189.38% | -97.49% | 23.91% | 66.27% | 15.80% |
| Average Basic Shares Outstanding | 18.72% | 92.14% | 28.31% | 41.56% | 39.99% |
| Average Diluted Shares Outstanding | 20.35% | 92.14% | 23.56% | 46.45% | 39.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |